Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
Asad Makhani,1 Miriam Thake,2 William Gibson1 1University of Alberta, Division of Geriatric Medicine, Edmonton, Alberta, Canada; 2Great Western Hospitals NHS Foundation Trust, Swindon SN3 6BB, UKCorrespondence: William GibsonUniversity of Alberta, Division of Geriatric Medicine, 1-198 Clinical Scien...
Guardado en:
Autores principales: | Makhani A, Thake M, Gibson W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b65e6b143e1944148ed126181816220e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder
por: Araklitis G, et al.
Publicado: (2020) -
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
por: Danny Ulahannan, et al.
Publicado: (2009) -
Acupuncture for Treatment of Overactive Bladder
por: Maryam Hosseini, et al.
Publicado: (2021) -
Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
por: Bilal Chughtai, et al.
Publicado: (2008) -
Update on duloxetine for the management of stress urinary incontinence
por: Maya Basu, et al.
Publicado: (2008)